Lead Extract Study
EXTRACT
EXTRACT Study (Data Collection on the Extraction of 2nd and 3rd Generation Defibrillation Leads)
1 other identifier
observational
100
1 country
1
Brief Summary
The recent expansion of indications for implantable cardioverter defibrillators (ICDs) has changed the population of patients being implanted. Younger and healthier patients are now being implanted for primary prevention of sudden cardiac death. Due to the younger population, the likelihood of the lead failing during the lifetime of the patient is higher and also more likely to need extraction. To reduce the risk of the lead extraction procedure and therefore reduce the number of abandon leads, ICD lead manufacturers are designing leads to offer improved chronic extractability to reduce the morbidity and mortality during these procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 28, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedJuly 26, 2010
May 1, 2009
3.3 years
May 28, 2009
July 23, 2010
Conditions
Keywords
Eligibility Criteria
Subjects who are scheduled for an ICD lead extraction
You may qualify if:
- Subjects must be 18 years of age or older,
- be scheduled for an ICD lead extraction and
- willing and able to sign the informed consent.
You may not qualify if:
- Patients with lead implant duration less than 6 months,
- patients with gross chronic lead infections,
- patients with epicardial or subcutaneous ICD systems (without transvenous ICD lead) and
- patients who are pregnant or suspect they may be pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Paul Heart Cliniclead
- Medtroniccollaborator
Study Sites (1)
St. Paul Heart Clinic
Saint Paul, Minnesota, 55102, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Pierce J. Vatterott, M.D.
St. Paul Heart Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 28, 2009
First Posted
July 26, 2010
Study Start
November 1, 2006
Primary Completion
March 1, 2010
Study Completion
May 1, 2010
Last Updated
July 26, 2010
Record last verified: 2009-05